APOA1 抗体 (C-Term)
Our Local Distributor
北京 101111
Quick Overview for APOA1 抗体 (C-Term) (ABIN783514)
抗原
See all APOA1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
特异性
- This antibody detects Apolipoprotein A I (APO AI) (C-term).
-
交叉反应 (详细)
- Species reactivity (tested):Human, chicken
-
纯化方法
- Affinity chromatography purified via peptide column
-
免疫原
- Raised against a 19 amino acid peptide near the carboxy terminus of human ApoA1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS containing 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freezing and thawing.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
别名
- Apolipoprotein A I (APO AI)
-
背景
- Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma, which is correlated with cardiovascular disease. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI
-
基因ID
- 335
-
NCBI登录号
- NP_000030
-
UniProt
- P02647
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
抗原
-